Stratasys is helping nasal swabs and COVID-19 testing

Posted on Updated on

According to Aaron Pearson, he is Vice President of Public Relations at Stratasys 3D Printing, “The need for widespread COVID-19 testing of millions of people has surfaced another shortage, nasal swabs. Stratasys has added to its efforts to fight the pandemic and ongoing testing requirements by marketing and promoting Origin 3D-printed nasopharyngeal (NP) swabs to healthcare providers and other testing centers in the U.S. The Origin 3D-printed nasopharyngeal swab has been tested in a clinical trial and is considered an FDA Class I Exempt Device.”

 

Nasal swabs and COVID-19 testing: the next step in the Stratasys pandemic response.

Advertisements

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.